Sellas to present new preclinical SLS009 data for pancreatic cancer
Sellas Life Sciences said three abstracts for SLS009 (Tambiciclib) have been accepted for poster presentation at a major oncology conference.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.